A qui tam False Claims Act (FCA) complaint was recently unsealed against Cerebral, a telehealth startup that provides virtual mental-health therapy, in the U.S. District Court for the Northern District of Iowa.
Continue Reading False Claims Act Case Unsealed Against Cerebral, Showing Continued Scrutiny of Telehealth PrescriptionsDistrict Courts Wrestle with Causation in Kickback Cases While Circuit Courts Remain Divided
Two Massachusetts federal district courts recently addressed—and disagreed about—an important False Claims Act (FCA) issue that has also divided the federal circuit courts: when an alleged FCA violation is based on an underlying violation of the Anti-Kickback Statute (AKS), what kind of causal link must the government or a relator show between the alleged AKS violation and the allegedly false claim for payment? Continue Reading District Courts Wrestle with Causation in Kickback Cases While Circuit Courts Remain Divided
FCA Risk for Private Equity Investment in Healthcare for Mergers & Acquisitions Magazine
We contributed an article addressing the mounting risks faced by private equity (PE) firms investing in the healthcare industry in the July/August 2023 issue of Mergers & Acquisitions Magazine. In the article, we delved into the complexities of this highly-regulated sector and the heightened attention it receives from government enforcement bodies.
Continue Reading FCA Risk for Private Equity Investment in Healthcare for Mergers & Acquisitions MagazineNinth Circuit Limits Damages in Government Procurement Case
On August 8, the Ninth Circuit issued a key decision clarifying two important aspects of damages under the False Claims Act (FCA) in the government procurement context.
Continue Reading Ninth Circuit Limits Damages in Government Procurement CaseRegister Now | How to Respond to a Civil Investigative Demand Webinar

Join us on September 13 for a webinar in which we will discuss responding to a government investigation and specifically responding to a CID.
Continue Reading Register Now | How to Respond to a Civil Investigative Demand WebinarFalse Claims Act Decisions to Know from Q2 2023
In this post, we summarize noteworthy False Claims Act (FCA) decisions from the second quarter of 2023.
Continue Reading False Claims Act Decisions to Know from Q2 2023False Claims Act Fundamentals: How to Respond to a Third-Party Subpoena
If you are part of a heavily regulated—or heavily litigated—industry, at some point, you or your company are likely to receive a third-party subpoena.
Continue Reading False Claims Act Fundamentals: How to Respond to a Third-Party SubpoenaRegister Now: The Supreme Court and the False Claims Act Webinar Replay
The Supreme Court recently released important opinions that will shape False Claims Act investigations and litigation for years to come.
Continue Reading Register Now: The Supreme Court and the False Claims Act Webinar ReplayMartin’s Point Health Care Inc.’s $22.4M Settlement Illustrates DOJ’s Focus on Part C Fraud
Last week, the U.S. Department of Justice (DOJ) announced a $22.4 million settlement resolving allegations that Martin’s Point Health Care, Inc. (Martin’s Point) violated the False Claims Act (FCA) by submitting inaccurate diagnosis codes for its Medicare Advantage Plan enrollees.
Continue Reading Martin’s Point Health Care Inc.’s $22.4M Settlement Illustrates DOJ’s Focus on Part C FraudExpect More Cyber-Enforcement under the False Claims Act
Earlier this month, the White House released the National Cybersecurity Strategy Implementation Plan outlining specific “high impact initiatives” that the federal government will carry out to achieve its cybersecurity objectives.
Continue Reading Expect More Cyber-Enforcement under the False Claims Act